21 results on '"Iacoviello Massimo"'
Search Results
2. 38 PERIPHERAL ENDOTHELIAL FUNCTION AND CARDIOPULMONARY FUNCTION IN PATIENTS AFFECTED BY PULMONRY HYPERTENSION
3. 391 NEUROLOGICAL DISORDERS AND TAKOTSUBO SYNDROME: CLINICAL FEATURES AND OUTCOMES. RESULTS FROM A MULTICENTER PROSPECTIVE EUROPEAN REGISTRY OF 2300 PATIENTS.
4. 782 RATIONALE AND DESIGN OF EFI-CHF (ENDOTHELIAL FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE TREATED BY SGLT2I)STUDY
5. 39 ECHOCARDIOGRAPHIC FINDING BETWEEN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION IN TREATMENT WITH ARNI AND SGLT2I
6. 387 MITRAL VALVE MORPHO-FUNCTIONAL FEATURES DURING THE ACUTE AND RECOVERY PHASE IN PATIENTS WITH TAKOTSUBO SYNDROME
7. 442 OVERWEIGHT AND TAKOTSUBO SYNDROME: SHORT- AND LONG-TERM OUTCOME. RESULTS FROM A MULTICENTER PROSPECTIVE REGISTRY.
8. 438 INCIDENT HYPOCHLOREMIA AMONG PATIENTS WITH TAKOTSUBO SYNDROME: SHORT- AND LONG-TERM OUTCOME. RESULTS FROM A MULTICENTER PROSPECTIVE REGISTRY.
9. The PONTE (PDTA FOR INTEGRATED FOLLOW-UP TERRITORY HOSPITAL OF THE PATIENT WITH CARDIAC HEART FAILURE) (BRIDGE) Heart Failure project: increased adherence to guideline-recommended therapies through web-based shared clinical database
10. 131 Cancer and takotsubo syndrome: clinical features, outcome, and inflammatory patterns. Results from a multicentre prospective registry
11. 24 Gliflozins and ventricular function in patients affected by chronic heart failure with diabetes mellitus
12. 25 Atrial remodelling in patients affected by chronic heart failure in therapy with sacubitril/valsartan
13. 180 Cognitive disorders in takotsubo syndrome: incidence, short, and long term outcome. Results from a prospective multi-centre registry
14. 61 Right ventricular function in patient with heart failure with reduced ejection fraction and sacubitril/valsartan treatment
15. 37 Prognostic role of the lung ultrasound in the acute coronary syndrome
16. 63 Peripheral endothelial function in patients affected by pulmonary hypertension. Relationship between endothelial function, haemodynamic parameters, and therapy response
17. ANMCO POSITION PAPER: Use of sacubitril/valsartan in hospitalized patients with acute heart failure
18. ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes
19. The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
20. ANMCO/SIC Consensus Document: cardiology networks for outpatient heart failure care
21. ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.